John Sigurd Mjøen Svendsen
Oprichter bij Pharmasum Therapeutics AS
Profiel
John Sigurd Mjøen Svendsen is the founder of Lytix Biopharma AS, which was founded in 2003.
He held the title of Board Member & Director-Discovery Research from 2012 to 2013.
Dr. Svendsen is also the founder of Pharmasum Therapeutics AS.
Currently, he is a Professor at the University of Tromso.
In the past, he worked as a Director at Prophylix AS and as a Professor at the Massachusetts Institute of Technology.
Dr. Svendsen obtained a doctorate degree from the University of Tromso.
Actieve functies van John Sigurd Mjøen Svendsen
| Bedrijven | Functie | Begin |
|---|---|---|
| University of Tromso | Corporate Officer/Principal | 14-05-2009 |
Pharmasum Therapeutics AS
 Pharmasum Therapeutics AS BiotechnologyHealth Technology Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway. | Oprichter | - |
Eerdere bekende functies van John Sigurd Mjøen Svendsen
| Bedrijven | Functie | Einde |
|---|---|---|
Prophylix AS
 Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Directeur/Bestuurslid | - |
| Massachusetts Institute of Technology | Corporate Officer/Principal | - |
| LYTIX BIOPHARMA | Oprichter | - |
Opleiding van John Sigurd Mjøen Svendsen
| University of Tromso | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LYTIX BIOPHARMA | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Prophylix AS
Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Health Technology |
Pharmasum Therapeutics AS
Pharmasum Therapeutics AS BiotechnologyHealth Technology Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway. | Health Technology |
